With the closure of ECCMID 2014, my two year period as the president of ESCMID is over. They have been two very busy years and I do not think my family, or my laboratory or EUCAST colleagues would have looked kindly at a longer term! The ESCMID Executive Committee, both regular and ad hoc members (see pages 4 and 5), is a boisterous crowd of scientists and CM and ID specialists. They all have lots of ideas about how to improve ESCMID and ECCMID, as well as the everyday work situation for colleagues in CM and ID, cooperation with other societies, return on investments (financial and otherwise), IT-support, communication and much more. It has been a pleasure and an honour, not to mention a challenge (!), to lead them during this period.
Message from the President
With the closure of ECCMID 2014, my two year period as the president of ESCMID is over. They have been two very busy years and I do not think my family, or my laboratory or EUCAST colleagues would have looked kindly at a longer term! The ESCMID Executive Committee, both regular and ad hoc members (see pages 4 and 5) , is a boisterous crowd of scientists and CM and ID specialists. They all have lots of ideas about how to improve ESCMID and ECCMID, as well as the everyday work situation for colleagues in CM and ID, cooperation with other societies, return on investments (financial and otherwise), IT-support, communication and much more. It has been a pleasure and an honour, not to mention a challenge (!), to lead them during this period.
Together we have organised two successful ECCMIDs: Berlin 2013 with Congrex as our congress provider, and Barcelona 2014 together with Kenes. We continue to make ECCMID grow and each new ECCMID seems to break the record of previous years, both in the number of submitted abstracts and in attendance. This year the number of abstracts exceeded 4'500. Only a few years ago the record was 2'900. ECCMID also seems to attract more and more people. In Berlin there were almost 10'000 of us and, at the time of writing, two months before ECCMID in Barcelona, the numbers are looking even better. It has become a truly international meeting, with attendees from all over the world; but despite its size it retains the qualities of a 'workshop'. It is the natural host of many satellite meetings, both large and small, covering research planning, Study Group meetings, committee meetings (like those of EUCAST, reporting on the last 12 months and plans for the next 12), meetings to write grant applications, to plan Postgraduate Courses or to arrange Observerships and much, much more. These 'meetings within the meeting' are the nerve and soul of ESCMID and ECCMID, and I am sure that is why we are successful. Do you feel, as I do, the constructive, friendly atmosphere among colleagues and friends in CM and ID? Do you find, as I do, many friends in 'unlikely places'? Do you enjoy, as I do, making our youngest colleagues feel wanted and welcome? Do you thrive on this, as indeed I do?
Together with successful ECCMIDs, we have been able to offer you medical guidelines, Postgraduate Courses, Summer Schools, scientific support in Study Groups (now almost 30 strong), research grants and awards, the now very popular ESCMID Observerships (some dedicated to public health Gunnar Kahlmeter ESCMID President gunnar.kahlmeter @ escmid.org through our cooperation with WHO Europe and ECDC), and the ESCMID Online Lecture Library where almost all ECCMID and many other lectures are available. Together with ECDC and EMA we also continue to give you harmonised antimicrobial breakpoints through EUCAST (the European Committee on Antimicrobial Susceptibility Testing) and a standardised European disk diffusion test, which is constantly under development.
The ESCMID Executive Committee will, when I hand over to Murat Akova, consist of four male colleagues, Murat Akova (ID, Turkey), Mario Poljak (CM, Slovenia), Jesús Rodríguez-Baño (ID, Spain) and myself for another two years as the Past President (CM, Sweden); and three female colleagues (Evelina Tacconelli (ID, Germany), Cornelia Lass-Flörl (CM, Austria) and Annelies Zinkernagel (ID, Switzerland). Our Programme Director for several years, Jordi Vila (CM, Spain) will hand over to Winfried Kern, (ID, Germany) . This means that a clear bias towards CM over the past few years will now be turned into an ID dominance with a good gender balance. Some of you may think that this influences everyday committee work and decisions but I can tell you that we only rarely take a stand as CM or ID specialists and we all try to make sure that ESCMID and ECCMID are balanced in every possible way; CM and ID, north and south, west and east, male and female. It is often difficult and sometimes not achieved but this is our aim.
Although this is a handover to Murat Akova in the fine tradition of ESCMID, I shall continue to work for ESCMID and, above all, on behalf of all ESCMID members and ECCMID attendees hoping for even better ECCMIDs, more Postgraduate Courses and Observerships, more attendance and research grants and more learning opportunities followed by job opportunities. Finally, I shall continue my endeavours to provide even more support for all of you from EUCAST.
When I joined the ESCMID Executive Committee in 2007, Giuseppe Cornaglia, then the Incoming President, asked in his article in an ESCMID Newsletter 'What will ESCMID look like in a couple of years' time?' Now, after almost seven years, one can frankly answer this question by saying 'the Society looks great!' As Gunnar Kahlmeter explains clearly in his column opposite, this is not simply because ESCMID now organises the world's most successful congress of Clinical Microbiology and Infectious Diseases. ESCMID also gathers the best scientists from Europe and elsewhere to work with the Society, embraces young physicians and scientists and offers them many educational activities, and gives them opportunities to express their ideas and influence the future of our profession. ESCMID provides them with grants to maintain their research and attend ECCMIDs, courses and Summer Schools. Now, it is my turn to ask the very same question: What future awaits ESCMID in the coming years? Considering the challenges we currently face, there is no easy answer. However, I suggest that three terms stand out as our priorities: networking, encouragement and synergy.
In ESCMID, networking has always been of major importance. To maintain the Society's attractiveness, networking should be even more extensive. Observerships, introduced a few years ago, have been a huge success because they foster understanding between countries. I hope to extend this part of our activity beyond Europe and beyond everyday working practice to include science and research.
ESCMID's future lies in the hands and brains of our young colleagues. Thus, we have to encourage them, allow them to take active roles and continue to provide them with every opportunity not only for their own research and education but also for their ideas and feedback to benefit the Society.
ESCMID must stimulate synergy. We have been very successful in showing that a laboratory discipline (microbiology) can complementarily join forces with a clinical speciality (infectious diseases). We have also managed to bring about very successful cooperation between our Study Groups working on diverse subjects. It should be possible to increase our work with numerous specialities, ranging from the main sciences to clinical medicine. In that sense, ESCMID should continue to foster its good working relationships with other global and local organisations, including WHO and ECDC, for the benefit of public health and attempt to create a system for a prompt, coordinated response to infectious diseases-related crises occurring anywhere in the world.
Obviously, to achieve all these ambitious desires requires teamwork. My teammates, who are magnificent scientists and hardworking professionals, include the Executive Committee and our Executive Office in Basel as well as those who take responsibility on various committees and subcommittees. But it also requires financial resources, which, historically, are sometimes more and sometimes less abundant. Our management of these resources will be crucial for our future success. ESCMID's current success would not have been possible without the vision and inexhaustible energy of all the superb presidents of the Society, some of whom I have had the privilege to serve during the past seven years. Their passion and wisdom, while transforming ESCMID from a local organisation in its early days to a global society, inspire me to take on such a challenge for the next two years. What does the future hold for ESCMID? More networking, more encouragement and more synergy and, together with appropriate financial resources, more success! Murat Akova ESCMID Scientific Affairs Officer, President-elect & Secretary General murat.akova @ escmid.org Message from the Incoming President ESCMID -about the Society ESCMID -reaching out to the world from its Swiss hub Since May 2011 ESCMID has been based in Switzerland and continues to provide services and activities that longstanding members have come to appreciate. We are pleased to report that the Society has now grown to more members than ever -5'587 -an increase of over 15% compared to 2013! From this year everyone with an ESCMID login or membership may use this to register for ECCMID. We believe this has made the process more user-friendly and it's easier for participants to save on registration fees by purchasing a membership beforehand. As seen in Figure 1 , the largest portion of our membership is in Europe, yet some of our top 40 countries are in North America, Asia and Africa (Figure 2 ), and we have members from 109 countries worldwide, proving that we are not just attractive to European professionals.
The annual congress, ECCMID, is the Society's biggest annual event. It is now the largest congress of its kind in the fields of CM and ID. However, the Society has much more to offer than the annual meeting! Gunnar Kahlmeter ESCMID President gunnar.kahlmeter @ escmid.org To facilitate the professional life and careers of our young colleagues, we offer a variety of programmes that especially target members still at an early stage in their careers including: • ESCMID Observerships, including special Observerships with ECDC and WHO • Travel Grants for the annual congress -ECCMID • Travel Grants for ESCMID courses, workshops and conferences • ESCMID Online Lecture Library (OLL) • Option to participate in the Trainees Association of ESCMID (TAE) • ESCMID Research Grants • ESCMID Summer School Other core benefits of ESCMID membership include: • ESCMID Collaborative Centre programme -to host Observers • Post-graduate courses -continuing education • Scientific conferences on special topics • The Society's Journals -CMI and NMNI • ESCMID guidelines -medical and laboratory • European projects -e.g. EUCAST • Study Groups -expert groups on specific topics One of the Society's main strengths is its facilitation of networking inside Europe. ESCMID has over 50 Affiliated Societies that provide input into our activities and whose members we regularly contact. Collaboration with ECDC and WHO has strengthened -both actively participate in ESCMID and ECCMID activities. To reach out beyond Europe, ESCMID delegations regularly travel to conferences and meetings all over the world, as far afield as Russia, India, China and Brazil.
We invite you to visit our website and explore our many resources. ESCMID Executive Committee Elections Held in 2013 I am very pleased to be elected as a member of the ESCMID Executive Committee. As a physician/scientist I strive to combine basic research with patient care. I am highly motivated to expand this work. Together with the other members of the Executive Committee and ESCMID members I shall strive to further evolve and consolidate basic as well as clinical research. Further, my involvement with ESCMID will be to enhance educational, professional and scientific activity in order to solidify ESCMID as 'the' scientific and clinical organisation for all issues related to infectious diseases. We are pleased to present the recipients of awards and grants for the year 2014. ESCMID continues its strong commitment to the grant programmes, as evidenced by our support of 13 individuals for an ESCMID Research Grant as well as our generous allocation of funds for ECCMID travel grants. In 2013 attendance grant funding for courses and conferences increased by some 60%, demonstrating our commitment to continuous learning and exchange. Ilaria Capua (Padua, Italy) is the ESCMID Excellence awardee for 2014. In addition to the publication of more than 200 scientific papers, many of which were published in leading international peer-reviewed journals, she has also played a key role in launching global initiatives, served on international committees and received numerous accolades. Her lifetime achievements and contribution to research, particularly in the management of avian influenza viruses and other animal viruses, have significantly influenced recent intervention strategies developed for animal and, consequently, human health issues.
Position and affiliation
The Young Investigator Awardees for 2014 are Michael Ramharter (Vienna, Austria) and Joost Wiersinga (Amsterdam, The Netherlands). Michael Ramharter has been pivotal in the pre-clinical and clinical development of anti-malarial drugs, with a focus on Central Africa and paediatric patients. Joost Wiersinga's field of interest is sepsis, and he has an excellent track record for the interplay between severe infections and host response, combining experimental animal studies, laboratory investigations and clinical studies.
The recipients of the 2014 Trainee Association of ESCMID Awards for Training Achievements are Liliana Praticò in Infec-tious Diseases (Pavia, Italy), Neven Papić in Infectious Diseases (Zagreb, Croatia) and Yusuf Erlangga in Clinical Microbiology (Brussels, Belgium).
The International Sepsis Forum (ISF) Award recipient for 2014 is Jacqueline M. Lankelma (Amsterdam, The Netherlands).
Thirteen young colleagues received an ESCMID Research Grant in 2014 to work on their proposed basic or applied research projects. The choice was exceptionally difficult this year as we received a record number of 145 research grant applications of high-quality. Every year one of those receiving a grant is also awarded the ESCMID/FEMS fellowship and this year it goes to two recipients. We are truly thankful to the large number of Research Grant Reviewers who dedicated their time and energy to evaluate all these applications thoroughly. We proudly acknowledge our Reviewers by name on page 61.
In addition, ESCMID supports young colleagues with merit-based travel grants and free registration to enable them to attend ECCMID. We gave more than 100 young scientists travel grants and free registration for ECCMID Barcelona, where they will present the results of their work. ESCMID also supports its young members with attendance grants for ESCMID conferences, the Summer School, post-graduate educational courses and other educational and/or scientific events. In 2013 ESCMID spent 60% more on these activities compared to 2012.
You can find details of all recipients of awards and research/travel grants for 2014 on the following pages.
Awards and Grants 2014
ESCMID had a successful 2013, having been through a period of profound transformation, both organisationally and financially, in 2011 and 2012. In 2013, with our seat in Switzerland well-established, we spent EUR 0.5 million more on key activities than in 2012 (see graph). This applies especially to the Scientific Affairs sector, where we doubled our expenses, since this field encompasses our core competencies and is essential to the future of the Society.
The 2014 budget foresees expenditures of approximately EUR 3.4 million, mostly concentrated in the areas of Science, Professional Affairs and Education (Figure 1 ). ESCMID is proud to keep supporting previously successful projects and is committed to funding new scientific and educational activities, including Study Groups, conferences and workshops, medical guidelines, awards and grants. She has extensive experience in coordinating international research projects funded by the European Commission, and has also worked closely with FAO, managing Technical Cooperation Projects covering 40 countries, and with OIE in international activities and twinning projects. She is author or co-author of over 200 publications in peer-reviewed journals as well as editor of scientific books and of books and articles for the general public. In 2006 she ignited an international debate on enhancing interdisciplinary collaboration to foster transparency of genetic data of influenza viruses, which has promoted a review of international health policies on data sharing to improve pandemic preparedness.
ESCMID Award for
In 2007 
Research interests
Her areas of research include viral diseases of birds, mammals and fish, with particular reference to zoonotic viral infections. Her group is actively involved in the epidemiology, evolution and phylogeny of avian influenza viruses and in the development of novel vaccines for influenza infections. In addition, studies on interspecies transmission mechanisms and on the metabolic consequences of influenza infection have become core parts of her research activities. The group also functions as an international reference laboratory for rabies and lyssaviruses, which is involved in molecular evolution studies and the development of novel control and prevention strategies. Other areas of interest include diagnosis and control of Newcastle disease and coronavirus infections in poultry, pathogenesis and vaccine development for viral diseases of fish and poultry and research on selected viral zoonotic agents, including astroviruses, West Nile virus and related flaviviruses. The application and integration of advanced tools in molecular genetics and bioinformatics for research focusing on infectious diseases at the animal-human interface is also a key activity of her group.
Ilaria Capua will be presented with her award during the ESCMID Excellence Award ceremony by Gunnar Kahlmeter, ESCMID President, and Giuseppe Cornaglia, ESCMID Past President, on Monday, 12 May 2014, 14.30 -15.30 in Hall C. During this ceremony she will give her recipient's lecture: 'Close encounters of the third kind -pathogens and globalisation'. 
Michael Ramharter

Research Interests
Starting from the preclinical evaluation of antimalarial drugs, he developed a strong interest in the clinical development of antimalarial combination therapies. He has led a series of clinical trials investigating novel drugs and drug combinations for the treatment and prevention of malaria in children and pregnant women -two of the most vulnerable patient populations in sub-Saharan Africa. Besides malaria, his main research activities focus on the epidemiology and management of neglected tropical diseases including schistosomiasis and echinococcosis and other infectious diseases occurring in the tropics.
Michael Ramharter will be presented with his award during the ESCMID Young Investigator Awards Session on 13 May 2014 at 11. 30 -12.30 in Hall E. During the session, he will present his work: 'Development of antimalarial drugs in Lambaréné, Gabon'. 
Joost Wiersinga
Collaboration is key
Since SGs have to apply for ESCMID funding for their various projects, competition is increasing with the growing number of SGs. We counter unnecessary competition by stimulating SGs to collaborate on proposals for research projects when applying for SG Research Grant funding, when submitting suggestions for ECCMID sessions, or when proposing free-standing courses as part of the annual Education Programme. A good example is the Education Programme 2014 in which 9 of the 17 Postgraduate Education Courses accepted were proposed and are organised by two or more SGs (see forthcoming events, page 59). A paradigm of internal collaboration within an SG is the new Open Virtual Learning Community (http://esgap.escmid.org), a new knowledge and networking resource on antimicrobial stewardship by our Antibiotic Policies group (ESGAP). Building this resource involved an intensive time of close collaboration of many experts to gather and combine the information. Now the scientific community can both profit from and contribute to it, openly and freely, focusing on the exchange of experiences and comments.
Scientific Affairs Subcommittee meeting in 2013 (l. to r.) Hanan Balkhy, Marek Gniadkowski, Hakan Leblebicioglu, Henri Saenz, Hervé Pelloux, Birgitta Evengård, Maiken Cavling Arendrup, Rosemary Barnes, Murat Akova, Paul Savelkoul, Germán Bou
Another good example of collaboration on different levels is the topic 'New Life for Old Antibiotics'. Our PK/PD of Anti-Infectives group (EPASG) and ESGAP received an SG Research Grant to create an inventory of dosing regimens for old antibiotics that need updating to optimise and preserve their efficacy. With the help of the ESCMID office, the information was published on a dedicated website (http://epasg.escmid.org) now allowing for comment and information exchange. When the principle investigator, Dr Ursula Theuretzbacher, came up with the idea of holding a conference on this topic, the ESCMID Executive Committee decided to make it an official ESCMID Conference (www.escmid.org/Vienna2014), and to fund it completely.
Murat Akova ESCMID Scientific Affairs Officer, President-elect & Secretary General murat.akova @ escmid.org www.escmid.org/science
The main task of the Scientific Affairs Subcommittee (SAS) is to have a close eye on the activity of all SGs. This implies a monitoring function but, in reality, it usually means working together with SGs with the aim of creating new projects, new initiatives or even new roles for SGs. An example from 2013 is when SAS asked SGs to offer their expertise and to contribute as reviewers to evaluate the many Research Grant applications. This worked fine and I heartily thank all reviewers and the related SGs for undertaking this new activity (see page 61). Every year in the Scientific Affairs Meeting (see picture of the 2013 meeting), SAS and all SGs come together to discuss everything, from individual projects to the future of science.
New SAS tasks
As science is constantly developing, the tasks of SAS change slightly from time to time. This year SAS acquired the new task as advisory board for the Medical Guidelines Director, to use their expertise to help assess the diverse guideline and consensus statement proposals. I look forward to this new opportunity for fruitful collaboration.
To close the circle, I would like to say a special thank you to all the members of SAS and all active SG members; only their constant commitment and involvement enables our Society and the whole scientific community to advance. Table- 1.
(1) Candida spp. play a prominent role among the common bloodstream isolates in our centre.
(2) Among all Candida species, C. albicans has been the most common cause of candidemia and this trend has not changed during the study period.
(3) Resistance to tested antifungal drugs is not common among our candidemia isolates except for itraconazole.
(4) We observed decreased susceptibility to fluconazole for our C.glabrata strains. This is possibly due to the intrinsic feature of this species for susceptibility to fluconazole and the conclusive nonexistence of the category of "susceptible" in the currently revised breakpoint scale. 
Methods
Results
C.glabrata (12) - 11 - 1 C.glabrata (10) IE IE IE IE C.krusei (5) PT PT PT PT C.krusei (4) 3 IE 1 - C.parapsilosis (22) 20 2 - - C.parapsilosis (17) 17 - - - C.tropicalis (18) 17 1 - - C.tropicalis (15) 15 - - - Itraconazole C.albicans (93) 88 4 - 1 Caspofungin C.albicans (45) 45 - - - C.glabrata (8) 1 6 - 1 C.glabrata (4) 2 - 2 - C.krusei (3) 1 1 - 1 C.krusei (3) 2 - 1 - C.parapsilosis (18) 16 2 - - C.parapsilosis(29)
Conclusions
Introduction and Purpose
CAESAR Project
The Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR) project is a joint initiative of ESCMID, The Netherlands National Institute for Public Health and the Environment (RIVM) and the World Health Organization (WHO) Regional Office for Europe. The aim of CAESAR is to set up a network of national surveillance systems of antibiotic resistance in all countries of the WHO European Region that are not part of EARS-Net, by using similar methodology. CAESAR is an important step towards the implementation of the European strategic action plan on antibiotic resistance adopted by the WHO-EURO Regional Committee 61 in Baku, Azerbaijan, in September 2011.
Country assessments
WHO-Europe, in collaboration with ESCMID and RIVM, performs country assessments to determine Member States' status with respect to the prevention and control of antibiotic resistance through surveillance, prudent use of antibiotics and infection control. It specifically focuses on promoting national coordination and strategy, strengthening AMR surveillance and improving clinical microbiology practice. The team meets (during one week as feasible) for discussions with relevant stakeholders and organisations at national, regional and local level. In 2013 country assessments were performed in Armenia, Azerbaijan, Belarus, Georgia, Kyrgyzstan and Uzbekistan.
National and sub-regional CAESAR workshops CAESAR workshops were held in countries that are at the stage of setting up or strengthening their national AMR surveillance. In 2013 workshops were held in Turkey, The former Yugoslav Republic of Macedonia, Belarus, Serbia and Bosnia and Herzegovina.
At ECCMID last year, the first CAESAR network meeting brought together the national AMR Focal Points of the first 8 countries engaged in CAESAR, the CAESAR project group and a pool of experts. Challenges, opportunities and needs in setting up or strengthening national AMR surveillance were discussed.
From 6 -8 November 2013 WHO/Europe organised a regional workshop on Surveillance of Antibiotic Resistance, Consumption and Raising of Awareness hosted by RIVM in collaboration with ESGARS-ESCMID, University of Antwerp and BAPCOC, Belgium.
External Quality Assessment of CAESAR laboratories
In November 2013 a first EQA for Antimicrobial Susceptibility Testing for 121 laboratories in nine countries engaged in CAESAR was performed by UK NEQAS. Results of this EQA will be discussed at the second CAESAR network meeting at ECCMID 2014.
CAESAR data collection
So far data have been collected according to CAESAR methodology in The former Yugoslav Republic of Macedonia, Serbia, Switzerland and Turkey. We plan to include results from three more countries in the first CAESAR annual report that will be issued at the end of 2014.
CAESAR project group
Nienke van de Sande (WHO EURO); Danilo Lo Fo Wong (WHO EURO); Christian Giske (ESGARS-ESCMID); Robert Skov (ESGARS-ESCMID); Jos Monen (RIVM-CIb); Tjalling Leenstra (RIVM-CIb).
CAESAR meeting at ECCMID 2013, Berlin, Germany
Nienke van de Sande WHO Regional Office for Europe NVS @ euro.who.int ESCMID Medical Guidelines www.escmid.org/guidelines Murat Akova ESCMID Scientific Affairs Officer, President-elect & Secretary General murat.akova @ escmid.org ESCMID actively supports the publication of high-quality, evidence-based guidance to support best medical practice in the diagnosis and management of infectious disease. The guidance is based on current best evidence and is intended to support patient management, although this of necessity demands the careful consideration of all issues relevant to a particular patient.
ESCMID supported guidance may be in the form of Clinical Practice Guidelines, Consensus Statements or Technology Reviews. The table below lists currently ongoing and recently completed guidance projects. The diligent work of all partnering Study Groups and Societies in these projects is greatly appreciated.
On the Medical Guidelines website (see top of page for direct link), you can find published guidelines written, endorsed or otherwise promoted by ESCMID; furthermore, there are detailed instructions if you want to submit a proposal for guidelines yourself.
Roger Finch has been Medical Guidelines Director since 2012. In the name of the entire Executive Committee, I would like to warmly acknowledge his strong commitment to overseeing and stimulating the diverse guideline projects during his term of office. He also intensively contributed to the further development of simple, comprehensive operating procedures to make it much easier for you, the project proposers and managers, to propose and run such complex projects.
ESCMID will introduce William Hope as the new Medical Guidelines Director during ECCMID 2014 in Barcelona, with the Scientific Affairs Subcommittee newly enlisted as advisory board.
We are looking forward to your proposals for new guidelines.
Guideline
Owner The 23rd ECCMID, held in Berlin from 27 to 30 April 2013, was remarkable for two reasons. The quality of the abstracts presented was outstanding, showing the excellence of research in the fields of clinical microbiology and infectious diseases in Europe, and we had the largest technical exhibition an ECCMID has ever had, despite the economic crisis. The Programme Committee devised a balanced scientific programme for both specialties, including bacteriology, virology, microbacteriology, mycology, parasitology and infection control from the diagnostic, prevention and treatment points-of-view. A big thank you to all members of the Programme Committee for their achievements in setting up such an interesting programme. Thanks also go to more than 200 reviewers, who conducted a blind review of the abstracts. As we do every year, we have received some complaints about specific abstracts being rejected. In 2013, of the 3'602 submitted abstracts (Figure 1) , just above 30% were rejected. Many excellent abstracts inevitably had to be excluded because of time and space constraints but this contributed to the extremely high quality of the presentations and posters. The most popular topics of accepted abstracts were: diagnostic/laboratory methods (other than molecular) (288 abstracts), molecular bacteriology (207), resistance surveillance (187), antibiotic usage (156) and infection control (152).
Jordi Vila ECCMID 2013 Programme Director jordi.vila @ escmid.org
The congress programme consisted of 20 Educational Workshops, including the TAE Trainees Day, 12 keynote lectures, 16 meet-the-expert sessions, 64 official symposia, 33 oral sessions and 19 integrated symposia. The total number of speakers and chairs was 345. Figure 2 shows the wide distribution of the countries of origin of the speakers. The contact time during keynote lectures, symposia, educational workshops, meet-theexpert sessions and oral sessions hit an all-time high of more than 260 hours. Although over 65% of Congress participants were logically from Europe, we were pleased to see increased percentages of participants from North and South America, Asia and Africa (Figure 3 ). This trend reflects our Society's efforts to extend our activities beyond Europe, especially in fast growing economic areas.
All delegates who attend ECCMID are welcome to get in touch with us with any comments or criticism that can help improve the meeting. 
Main educational activities in 2013
Never before in the history of ESCMID have so many proposals for educational courses been submitted as there were in 2013. From the 26 proposals, the Education Subcommittee chose nine educational courses and five technical workshops. ESCMID Study Groups joined forces with many foreign institutes to organise a splendid array of opportunities for professional development, becoming more and more involved in ESCMID's Education Programme and contributing greatly to ensure its high quality. In addition, ESCMID and the Society for Healthcare Epidemiology of America (SHEA), offered the 15th Training Course in Hospital Epidemiology in Brussels, in conjunction with the Aesculap Academy. For a few intensive days, participants were offered one of three modules for interactive training that has practical applicability to their own hospital settings.
The courses were held in cities across Europe, from Porto to Izmir and from Madrid to Athens. Three were in Spain: two technical workshops and an educational course, while Italy and Switzerland hosted two educational courses and two technical workshops, respectively. The number of participants varied according to the format of each course, ranging from 20 participants for certain lab-based workshops to over 120 for other formats. The activities were determined by the host Study Group with a view to providing up-to-date information or a practical approach.
The 12th Summer School took place in the seaside town of Vravrona, Greece, from 6 -13 July 2013. There were 55 participants from 21 countries at this year's event, which everyone enjoyed, particularly as they could follow their intensive study with a dip in the Aegean in the evening (see separate report).
ESCMID helps young members to attend courses and workshops by offering them grants. Some of our young colleagues struggle financially, especially when practising in countries with a much lower cost of living than that where the courses are held. The course organisers, with the help of the ESCMID Executive Office, select the recipients. The Education Programme provides excellent opportunities for young members to develop professionally so please encourage your less well-off and inexperienced colleagues to apply for courses and, where necessary, funding. While attending courses and workshops in person brings the most benefit, all members have access to the Online Lecture Library (OLL), which includes presentations of all our educational activities and is available to ESCMID members at www.escmid.org/OLL.
Outlook for 2014 and 2015
One course in 2014 will be located in São Paulo, Brazil, while the rest of the 17 postgraduate courses and technical workshops will, as usual, be held in cities across Europe. The number of proposals has increased to 28 and the standard has once again been extremely high, so the programme promises to be exciting. See the calendar section on the Society's website for full details of the 2014 Education Programme (www.escmid.org/calendar).
This year's Summer School heads back north, to Sigtuna, Sweden, from 5 -12 July 2014. Registration is already underway and details can be found online at www.escmid.org/summerschool.
We have already contacted all Study Groups and Affiliated Societies to ask for their ideas for the 2015 programme to be submitted by the end of May 2014 so we can meet our mid-July deadline for the full programme. Members are welcome to contact us with ideas for future courses and workshops and, of course, we highly recommend taking part in this year's programme. The 12th Summer School took place in Vravrona, Greece, from 6 to 13 July 2013, in a hotel located on a beautiful beach. We were slightly worried that the sea would be too tempting for the young people attending the course but, instead, it served as a way to relax after a day full of lectures, presentations and interactive sessions. This year's Summer School directors were George Petrikkos (Athens), Anna Skiada (Athens) and Mical Paul (Tel Aviv). They put together a very interesting programme, covering a wide range of topics in clinical microbiology and infectious diseases. The 34 lectures included various aspects of infections such as MDR bacteria, invasive fungal infections, influenza and other viral infections, HIV, endemic infections and infections in the immunocompromised host.
In addition, lectures about 'how to prepare a presentation' and 'how to publish the results of research' were very well received by the audience and considered really useful. There were also two pro-con sessions presented by the students and coordinated by members of the faculty, as well as five small-group tu-torials. Furthermore, all the students presented their research or some case reports and this gave them the opportunity to practise their skills and to ignite lively conversations.
There were 55 participants from 21 countries: Albania, Austria, Belarus, Bulgaria, Finland, Germany, Greece, Hungary, Italy, Latvia, Nigeria, Poland, Portugal, Romania, Russia, Saudi Arabia, Slovenia, Spain, Switzerland, Turkey and United Kingdom. Their vivacity and enthusiasm was transmitted to the 19 faculty members from five countries who supervised all the students' activities and were constantly available for further interaction, both scientific and social.
Overall, it was a very exciting experience for everybody. Many thanks to all the members of the faculty for sharing their expertise and knowledge and thus contributing to a very successful eventas successful as the previous Summer School in Innsbruck, Austria, and, I am sure, as the next one in Sigtuna, Sweden. Didier Raoult CMI Editor-in-Chief cmi.raoult @ gmail.com CMI appears monthly and includes peer-reviewed manuscripts, reviews and research notes. Each print and online issue includes a themed section, highlighting the key subjects CMI wishes to focus on. A guest editor assembles three to five invited reviews on the chosen topic, an editorial and related cover images. The following page shows all the themed sections published in 2013 and those scheduled for 2014. Elsewhere, 'Hot Topics' highlights particular infections and remains a very popular section of the journal. CMI also publishes well cited supplementary issues to cover ECCMID and conferences sponsored by partners.
13th ESCMID
Among the noteworthy developments of the past year is that CMI has published articles from countries with emerging economies; Madagascar for instance. This clearly confirms the willingness of the journal to be open to the world and not just advanced nations. It is also significant that China and Taiwan are among the top five countries submitting papers to CMI. However, while around a quarter of the papers submitted from Spain (the highest contributor) and the USA were accepted, the figure for those from China was only 9%. CMI editors continue to work with authors to improve the quality of papers coming from countries with cultural and organisational difficulties, enabling them to reach a standard more consistent with that of our own scientific community (Table 1) .
We have tried to balance the various topics covered by CMI. About a third of the journal concerns bacteriology, with epidemiology, mycology, infectious diseases and virology at between 11 and 18% each. Tropical and parasitic diseases account for 7.4%. The proportion of manuscripts submitted as original articles or as research notes (separate from invited reviews and editorials) is continually increasing ( Table 2 ).
In terms of citations and its impact, CMI is going from strength to strength. Figures for 2012 show increases in both the headline 2-and 5-year impact factors. The immediacy index (papers both published and cited during 2012) increased by over 25%, indicating that CMI is publishing highly topical material that is cited very soon after publication. Likewise, the Eigen factor (up 11%) and article influence score (up 8.2%) both indicate the journal's increasing prestige. CMI also passed a major milestone in 2013: our millionth full text download, achieving an alltime high of 1'092'747, up 34% on 2012 (see Figure 1 ). The two articles downloaded most often in 2013 can be found in Table 3 . For the next two years we want to stabilise the current size of the journal in order to better assess its real impact on the scientific community.
We are of course aware of how important it is for researchers to have their findings published quickly so we have been steadily reducing the time from submission to publication over the last two years. Publication online (Early View) now takes 32 working days (about six weeks, down from 55 in 2012 and 48 in 2013) and print publication takes on average 130 working days (roughly six months). We shall continue to streamline the process without compromising quality.
CMI strives to reflect ESCMID's academic activities and, more generally, the world of infectious diseases and clinical microbiology, as well as to attract the best articles and reviews. It also aims to draw attention to emerging fields and to questions raised in the themed sections. As always, we welcome feedback on our efforts and look forward to the challenges ahead. Microbes and infections ignore frontiers but clinical microbiology does not. A recent survey by Didier Raoult, Editor-in-Chief of CMI, showed that papers from emerging countries are still under-represented in infectious diseases and clinical microbiology journals (1). This is a shame, not only for the scientists from these countries but also for ID/CM scientists at large, and has a knock-on effect for health authorities and populations. Microbes and infections have always used the most advanced travel vehicles provided by humans to jump over frontiers and reach target populations. The frightening pandemic of the Beijing family of Mycobacterium tuberculosis, one of the major modern pathogens, illustrates this as it has invaded the whole world within only 20 years (2) . Therefore, it is of prime importance for us to leap over all boundaries and communicate as soon as possible any new event in clinical microbiology and infectious diseases because the evolution of microbes and outcome of infections is unpredictable. New Microbes and New Infections serves the field as a peer-reviewed, open access journal for the rapid dissemination of the latest research, with a particular focus on new genomes, new microbes, and new technology applied to the diagnosis of infectious/tropical diseases. As Editor-in-Chief, I am pleased to report that the first issue of this official ESCMID publication was issued in October 2013, papers having been solicited since May. Article categories include any country's first descriptions of a microbe, first noted resistance or first case reports, new genomes and new technologies for diagnosis. The journal welcomes mini-reviews as well as full length original articles. NMNI offers clinicians and researchers a rapid route to publication and the opportunity to circulate their work in a highly visible global forum. The sooner these new data are published, the sooner the issues they raise can be tackled.
Submission type
Scientists and medical practitioners in emerging countries have a great deal to contribute and NMNI is at the forefront of addressing the imbalance in papers from these countries. One key characteristic of this new digital journal is to break language barriers by being multilingual. Authors may submit manuscripts not only in English but also in one of five other languages. Papers will be handled by the most appropriate member of the Editorial Board, taking language into consideration. Its members are Tahar Kernif (Arabic), Jônatas Santos Abrahão (Portuguese), Wanderley de Souza (Portuguese), Ruifu Yang (Chinese), Wuguo Chen (Chinese), François Denis (French), Xavier de Lam-ballerie (French), Ogobara Doumbo (French), Oleg Medianikov (Russian) and Míriam-José Álvarez Martínez (Spanish). The journal offers a payment model affordable for any research group worldwide.
All articles published by NMNI are fully open access: immediately freely available to read, download and share.
New Microbes and New Infections -the title says it all and, to ensure the information is absolutely up-to-date, the editors strive for a one-month review period. NMNI is something we do want to go viral! ISSN: 2052 ISSN: -2975 Register for emailed New Microbes and New Infections table of contents alerts -the fastest and easiest way to stay informed on new research! E-alert registration is free and completely risk-free. You can opt out at any time. easy as 1, 2, 3 
NMNI New MIcrobes aNd New INfectIoNs
Setting up e-alerts on Wiley Online Library is as
www.escmid.org/jobs
The Job Platform is an easy way to find your next job or to fill an open position in CM and ID. Open positions are then published in the ESCMID newsletter and on the homepage. An overview of the current activities within the Professional Affairs' portfolios can be found on the following 8 pages. The ESCMID Collaborative Centres (ECCs) and Observership Programme is one of the most original and successful activities of our Society. Clinical Microbiology / Infectious Disease centres of excellence in Europe and beyond welcome ESCMID members from abroad to learn about diagnostic and therapeutic procedures and the local organisation of services, as well as to establish new contacts and foster international exchange. The ECC programme was launched in early 2009 and currently lists 67 fully operating centres (Figure 1) . The countries with the most ECCs are Spain (7), the Netherlands (7), the United Kingdom (6), Turkey (6) and Germany (5) ( Figure 2 ).
Many other European countries have not yet joined this initiative but it is ESCMID's intention to increase the number of ECCs outside Europe (Figure 1 
Activities within the ESCMID Collaborative Centre and Observership Programme
European Network Corner at ECCMID In recent years, the European Network Corner has had a dedicated area at ECCMID for ECCs to showcase their activities and connect with potential Observers. Also at this ECCMID, the European Network Corner will again have a dedicated area for ECCs to present themselves. 
ECC activity in 2013
In the past year ESCMID approved eight new institutions as Collaborative Centres, increasing the number of operating ECCs to 67. A Centralised Request Form for Observerships and ECC administration has been introduced to streamline the process.
Observer visits in 2013
In 2013 The ESCMID Parity Commission has been very active during the past year. After the ESCMID survey carried out in 2011, where semi-structured questionnaires were administered to 1'274 CM / ID professionals, we identified a need to further deepen our understanding of some of the most interesting results, this time through a mostly qualitative approach. Furthermore, the need to address all possible determinants of professional inequality besides gender also became apparent: national origin, ethnicity, religion, and sexual orientation. On the basis of such considerations, EPC decided to promote a research study aimed at integrating the 2011 ESCMID survey with additional information on a broader array of inequality factors in the CM / ID sector. Through this additional qualitative focus, the study, in its two components (quantitative survey and qualitative research study) will be able to represent a unitary, replicable model, both in time and in different disciplinary areas, countries and international societies among others. EPC is also actively working on a mentorship programme, designed to connect young or inexperienced CM/ID scientists, or those who want to improve in a specific area, with experienced practitioners willing to help them. ESCMID believes that the creation of this European network of mentors will provide extended opportunities to all ESCMID members to improve their research or advance their career level.
Recently, a surveillance study showed that in some European countries the prescribing of antibiotics in the community is significantly influenced by the gender of the patients (after adjusting for major clinical and epidemiological biases). To understand the contributing factors and characteristics of this phenomenon, EPC started a specific, systematic review of the literature and 'on site' analysis of antibiotics prescribing in selected European countries.
We trust that these projects will contribute to improve representativeness and balance, both in terms of career and research, among ID / CM professionals in Europe. EPC would be glad to work with all Society members to further define the next projects to be undertaken to reduce the areas of discrimination presently existing within the medical scientific community in Europe. Therefore, we encourage all our members to send their feedback and proposals for current and future activities of EPC to: parity @ escmid.org. Evelina Tacconelli, Professional Affairs Officer for Infectious Diseases evelina. tacconelli @ escmid.org Healthcare-associated infections (HAIs) are a leading cause of morbidity and mortality worldwide. Therapy is becoming ever more difficult because of the increasing rate of antimicrobial resistance among common HAI pathogens. Over the last decade, multidrug-resistant bacteria have been implicated in severe invasive infections and their occurrence has increased steadily. Patients are starting to see the rate of HAI and antibiotic resistance as an important indicator of quality of care. After presenting the first European Guidelines on infection control in Berlin, intended to reduce the spread of multidrug-resistant bacteria in hospitalised patients, ESCMID is going to increase its influence and involvement in infection control. A new ESCMID Committee for Infection Control was formed at the beginning of 2014 and had its kick-off meeting in March 2014. A list of members can be found below. Major goals will be: to harmonise infection control and preventive measures in all European countries and to reduce morbidity and mortality related to HAI. Development of new educational tools as well as specific guidelines and expert opinion with 'real life' applicability are a major focus. Research will be coordinated through dedicated networking. Questions about this programme can be directed to: infectioncontrol @ escmid.org.
Infection control and preventive measures: an ESCMID priority
A group of 10 observers (ESCMID members) are offered a 5 day programme at the European Centre for Disease Prevention and Control (ECDC) Observers and facilitators at WHO Regional Office for Europe
Trainee Association of ESCMID (TAE)
Polona Maver Vodičar TAE President polona.maver @ mf.uni-lj.si The young generation involved in the future development of CM/ID Founded in November 2009, the Trainee Association of ESCMID (TAE) represents a group of trainees and young specialists who finished their training fewer than three years ago. The TAE has a Steering Committee (SC) consisting of six elected members, three of whom are active in the field of clinical microbiology (CM) and the other three in infectious diseases (ID). In 2013 the very first TAE Steering Committee handed over the baton to their successors. With fresh motivation and youthful energy, we continue the initial idea of increasing and supporting the scientific and medical contribution of young clinical microbiologists and infectious disease specialists all over Europe.
On the first day of ECCMID 2013 in Berlin, TAE organised the third 'Trainees Day: a time for trainees to share their knowledge under the supervision of seniors'. This special session dedicated to trainees was an interactive event covering important epidemiological links between infections and animal exposure, surgical site infections and a workshop on how to produce high quality research papers. This year at ECCMID 2014 in Barcelona, TAE is preparing the fourth 'Trainees Day' with new, attractive and educational topics. In addition, we are actively involved in three other sessions presented at this year's ECCMID.
An ESCMID educational quiz composed of 20 questions with different levels of difficulty was run online from 1 September to 31 October 2013. Almost 200 participants from 40 different countries completed the quiz, demonstrating that this kind of online educational approach is very appealing.
TAE Steering Committee meeting at ECCMID 2013 in Berlin
Gunnar Kahlmeter ESCMID President gunnar.kahlmeter @ escmid.org In 2013 ESCMID invited ECDC and WHO to coorganise Observerships for ESCMID members. We quickly realised that these would have to be different from 'standard' ESCMID Observerships, that it would be more efficient to invite several people to visit at the same time and for them to interact with ECDC and WHO staff and each other as part of the Observerships. The aim is to familiarise ESCMID members with the public health efforts of these two important public health agencies. The reports from ECDC and WHO below speak to the success of the first series of Observerships.
In 2014 ESCMID, ECDC and WHO have all agreed to increase the number of invited Observers from five to ten for each of the two programmes. Breakpoints currently under discussion include those for several agents with Neisseria gonorrhoeae, Neisseria meningitidis and Acinetobacter spp. Following two rounds of wide consultation and protracted discussion on breakpoints for topical agents, it has been decided to publish a guidance note rather than breakpoints. 
EUCAST disk diffusion method
EUCAST MIC and zone diameter website
This presents collated MIC and zone diameter distributions of bacteria and fungi and the number of distributions included is constantly increasing (currently over 28'000). In addition, 
Antifungal Susceptibility Testing Subcommittee (AFST)
In 2013 the AFST Steering Committee consisted of Maiken C. Arendrup (Chairman), William Hope (Secretary), Cornelia Lass-Flörl and Manuel Cuenca-Estrella. The group has continued to define breakpoints for antifungal compounds and to revise and update reference methods for susceptibility testing of yeasts and moulds.
Micafungin breakpoints for Candida were released and fluconazole and anidulafungin breakpoints for Candida were revised. Rationale documents for these breakpoints were published on the EUCAST website and 'Technical Notes' summarising both these and voriconazole breakpoints for Aspergillus have been published in 'Clinical Microbiology and Infection' and 'Mycoses'.
In collaboration with CLSI, the AFST subcommittee documented problems in variability associated with susceptibility testing of Candida spp. affecting both EUCAST and CLSI methods, and this has led to common recommendations for the use of anidulafungin as a marker for caspofungin resistance (published by Ana Espinel-Ingrof et al. in Antimicrobial Agents and Chemotherapy). Additionally, a review that summarizes the EU-CAST AFST breakpoint setting process, including strengths and limitations and the existing breakpoints for Candida spp. and Aspergillus spp., was accepted for publication in Drug Resistance Updates. Currently, the EUCAST definitive document EDEF 9.2 'Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds' is being revised and itraconazole breakpoints for Candida have been proposed for consultation.
The structure of the AFST Steering Committee will be changed in spring 2014, from when it will consist of a Chairman (Maiken Cavling Arendrup, Denmark, a Scientific Secretary (Susan Howard, UK), a Data Coordinator (pending), a representative from the EUCAST Steering Committee (Johan Mouton, Netherlands) and two representatives of national committees (NACs): Manuel Cuenca-Estrella, Spain, and Cornelia Lass-Flörl, Austria. See EUCAST SOP 4.1 on the EUCAST website for details of subcommittee structure and organisation.
Subcommittee on the detection of resistance mechanisms and resistances of clinical and / or epidemiological importance
This subcommittee is chaired by Christian Giske. There has been extensive discussion and wide consultation on two drafts of a guideline document in 2012 -13. Version 1.0 of EUCAST guidelines on the detection of resistance mechanisms and resistances of clinical and /or epidemiological importance was released on the EUCAST website in December 2013. In 2013 -14 ESCMID has strengthened its links with Latin America by engaging in a number of activities together with both the Asociación Panamericana de Infectología (led by Luis Bavestrello) and individual partners.
In November 2013 ESCMID participated together with APUA and IUMS in the 2nd Meeting on Antimicrobial Resistance in Pathogens (Taller de Resistencia Bacteriana), held in Havana, Cuba. The first meeting took place in 2012 on the initiative of ESCMID and the Cuban Society for Clinical Microbiology and Infectious Diseases. Joint activities are being planned to further cooperation. ESCMID representatives were invited to give lectures at the University Cayetano Heredia in Lima, Peru. An important outcome of this visit is the establishment of the first ESCMID Collaborative Centre in South America with Eduardo Gotuzzo as host.
Once again ESCMID held a joint workshop during the Congress of the Asociación Panamericana de Infectología held in Santiago de Chile. The workshop focused on carbapenemases and it was coordinated by Maria Virginia Villegas.
In March 2014, ESCMID and SHEA together endorsed the Gram-Negative Bacteria Symposium within the VIII International Symposium on Antimicrobial Resistance, which was organised in Cartagena, Colombia, by the Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM).
Networking in Latin America
Guiseppe Corgnalia (r.) and Laurent Poirel (l.) For the eighth consecutive year, ESCMID has joined the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), chaired by Roman Kozlov, to organise an International IACMAC/ESCMID conference on antimicrobial therapy. The conference was held from 22 to 24 May 2013 in Moscow, Russia, and was attended by 1'221 participants from 67 regions in Russia. ESCMID representatives focused on future collaboration with IACMAC. On Monday, 29 April 2013 at ECCMID 2013, a special session was held with the Chinese Medical Association (CMA) and ESCMID. The purpose of the session was to get to know each other and to set up reciprocal visits. ESCMID is joining forces with CMA, TLID and ISID to organise a meeting on 'Infections and their control', to be held in Beijing from 19 -20 November 2014.
Cooperative Initiatives in the Russian Federation
In 2013 
